The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial

EuroIntervention 2012;7:1301-1309. DOI: 10.4244/EIJV7I11A205

1. Instituto Dante Pazzanese de Cardiologia, São Paulo, SP, Brazil; 2. Cardiovascular Research Center, São Paulo, SP, Brazil; 3. Hospital Universitari Vall D´Hebron, Barcelona, Spain; 4. Clinique Saint Hilaire, Rouen, France; 5. Tokuda

Aims: To demonstrate the acute and early outcomes of the novel Nile PAX dedicated polymer-free paclitaxel-coated stents (Minvasys SAS, Gennevilliers, France) in the treat

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Optimal diameter of diseased bifurcation segment: a practical rule for percutaneous coronary intervention